Sustainability Disclosures | Takeda Pharmaceuticals
Sustainability Disclosures
Our sustainability reporting is updated regularly and aligned with our policies, practices and data.
We continue to improve our data collection processes and reporting of environmental, social and governance (ESG) information to demonstrate our commitment to transparency and our stakeholders. This also allows us to measure our progress and identify risks and opportunities for our sustainable business growth.
2026 Annual Integrated Report
Our Annual Integrated Report summarizes our progress in FY2025 and how we’re building momentum and resilience in our growth journey as we deliver on our purpose of better health for people and a brighter future for the world.
2026 ESG Databook
Our ESG Data Book provides a complete list of Takeda’s corporate-level ESG metrics and the assurance statement from our independent auditors.
Learn more about our positions on important issues that arise in realizing our purpose and vision as a global, values-based, R&D-driven biopharmaceutical company.
Other Sustainability Disclosures
Patient
Read more about our approach to R&D and access to our medicines.
Values-based Governance
- Takeda's Human Rights and Modern Slavery Statement FY25
- Takeda's Human Rights and Modern Slavery Statement FY24
- Total Tax Contribution
- Country-by-Country Taxation Reports
Read more on our Ethics and Transparency Disclosures pages